Navigation Links
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Date:8/4/2011

$3.5 million and $37.7 million of which was recognized, respectively, as collaboration revenue for the three and six months ended June 30, 2011. The remaining $22.3 million is deferred revenue and will be amortized as collaboration revenue over the estimated obligation periods.

Research and development (R&D) expenses for the three and six months ended June 30, 2011 were $7.3 million and $18.8 million, respectively, compared to $8.2 million and $18.0 million, respectively, for the same periods in 2010. For the three months ended June 30, 2011 compared to the same period in 2010, the decrease in R&D expenses was due primarily to a decrease in clinical and other project expenses to support the LEVADEX Phase 3 clinical program, partially offset by an increase in personnel related expenses including stock-based compensation. For the six months ended June 30, 2011 compared to the same period in 2010, the increase in R&D expenses was due primarily to an increase in personnel related expenses including stock-based compensation, partially offset by a decrease in other expenses.  

Sales, general and administrative (SG&A) expenses for the three and six months ended June 30, 2011 were $4.8 million and $9.6 million, respectively, compared to $3.9 million and $7.8 million, respectively, for the same periods in 2010. For the three and six months ended June 30, 2011 compared to the same periods in 2010, the increase in SG&A expenses was due primarily to an increase in personnel related expenses including stock-based compensation, and an increase in professional services expenses.

For the three and six months ended June 30, 2011, non-cash stock-based compensation and depreciation expense were approximately $2.0 million and $4.4 million, respectively.

About MAP PharmaceuticalsMAP Pharmaceuticals is an emerging biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
2. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
4. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
5. Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results
6. Access Pharmaceuticals Adds Blue Cross Blue Shield of Hawaii, SummaCare and AvMed to MuGard Payer List
7. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
9. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
10. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
11. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 A study using ... offered a new look at the composition of carotid ... physicians understand and treat the disease, a leading cause ... Baptist Health Lexington between September 2010 and May 2012, ... Journal of the American College of Cardiology (JACC) ...
(Date:9/30/2014)... 30, 2014  HealthLoop® released an app version of ... iOS 8 and allows people to share medical device ... native iOS technologies to enhance the HealthLoop experience for ... with their doctors between visits. "This ... they collect is exciting," says HealthLoop founder Dr. ...
(Date:9/30/2014)...  Georgia-Pacific Professional is a leading provider of ... wide range of away from home applications. Building ... healthcare, including hospitals, long-term care facilities, surgical centers ... healthcare products and solutions to the dental community. ... infection control in the dental office," said ...
Breaking Medicine Technology:New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3
... (Nasdaq: THOR ), a world leader in device-based ... hearts, today announced that it will report its operating results ... 2010 on Thursday, October 28. The company will ... operating activities open to all interested parties at 1:30 p.m., ...
... 22 Bacterin International Holdings, Inc. (OTC Bulletin ... is scheduled to present at the upcoming Singular Research 5th ... 2010 at 3:20p.m.(PT) at the Luxe Hotel Sunset Boulevard, Los ... Bacterin, and John Gandolfo, Bacterin,s chief financial officer, will review ...
Cached Medicine Technology:Thoratec Schedules Third Quarter Conference Call, Webcast 2Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference 2
(Date:9/30/2014)... September 30, 2014 Catalent Pharma ... advanced delivery technologies and development solutions for drugs, ... full agenda for the 25th Annual CPhI Worldwide ... October 6th to 9th. , Catalent is showcasing ... expansions during the show, including its facilities in ...
(Date:9/30/2014)... Coast Dental and Orthodontics is ... practice, located at 1010 Shaw Avenue in Clovis, CA. ... services , and specialty dental care including orthodontics, endodontics, ... and convenient dental care, our Clovis dentists also strive ... Coast Dental at 559-777-6113 to schedule an appointment. , ...
(Date:9/30/2014)... September 30, 2014 With accolades like the ... Lash Masters II, Hilaree Brand of My Brand Lashes is ... craft and, more importantly, the ability to teach. She leads ... credentials and a great reputation. , With a background in ... a Master of Aesthetics and as an Instructor. She has ...
(Date:9/30/2014)... NY, September 30, 2014Levothyroxine (L-T4), long the standard ... most patients, but some individuals do not regain ... thyroid physiology may help to explain these differences. ... Association on thyroid hormone replacement reviewed the latest ... to determine whether a change to the current ...
(Date:9/30/2014)... Pittsburgh School of Dental Medicine have been awarded a ... Dental and Craniofacial Research, part of the National Institutes ... roots of cleft lip and cleft palate and to ... the Philippines and Pennsylvania. , Orofacial clefts (OFCs), ... that can form when a baby,s mouth doesn,t develop ...
Breaking Medicine News(10 mins):Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 2Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 3Health News:New hypothyroidism treatment guidelines from American Thyroid Association 2Health News:Pitt team searches for genetic roots of cleft lip, palate 2
... latest advancement in aspirin delivery ... ... has,rolled out Fasprin(R), a patented, 81 milligram aspirin tablet that,dissolves rapidly ... solution for the millions of Americans who maintain a,daily aspirin routine ...
... Formulas No Better than Generic Store-Brand Infant,Formulas, Says Mayo Clinic ... ... GORDONSVILLE, Va., Nov. 13 The Mayo Clinic, a ... every type of complex illness, now offers an online resource ...
... Awareness and Funds to Fight Homelessness in Los ... LOS ANGELES, Nov. 13 United Way of Greater ... to fight homelessness on,Saturday morning, November 17, 2007, by ... Exposition Park near downtown Los Angeles.,HomeWalk will engage participants ...
... Groundbreaking Meeting Brings Together Cancer Funding Organizations, Advocates, Government ... ... Pharmaceutical Industry, NEW YORK, Nov. 13 Leadership ... and advocacy groups met,on November 1-2 along with experts ...
... of America (GSA) has chosen W. Andrew Achenbaum of ... the Donald P. Kent Award. This distinguished honor is ... the highest standards for professional leadership in gerontology through ... society. , The award presentation will take place ...
... chosen Nancy L. Pedersen of Sweden,s Karolinska Institutet to ... to Gerontology. This prize is given annually to an ... new synthesis and perspective or have yielded original and ... literature. , The award presentation will take place at ...
Cached Medicine News:Health News:New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen 2Health News:Mayo Clinic Supports Store-Brand Infant Formulas 2Health News:United Way of Greater Los Angeles and Fannie Mae Foundation Announce 3000 Marchers for HomeWalk 2007 2Health News:United Way of Greater Los Angeles and Fannie Mae Foundation Announce 3000 Marchers for HomeWalk 2007 3Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 2Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 3Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 4
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... technology allows the grasper ... a shorter length and ... the stone. The Unidex ... one-handed operation. Supplied sterile ...
Bugbee Fulgurating...
Fulgurating Electrode, 2 F...
Medicine Products: